Key statistics
On Monday, Pliant Therapeutics Inc (PLRX:NSQ) closed at 1.16, 5.44% above its 52-week low of 1.10, set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.25 |
---|---|
High | 1.29 |
Low | 1.14 |
Bid | 1.16 |
Offer | 1.23 |
Previous close | 1.25 |
Average volume | 2.10m |
---|---|
Shares outstanding | 61.39m |
Free float | 59.03m |
P/E (TTM) | -- |
Market cap | 76.73m USD |
EPS (TTM) | -3.61 USD |
Data delayed at least 15 minutes, as of Jun 30 2025 21:00 BST.
More ▼
- Pliant Therapeutics Provides Update on BEACON-IPF
- Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference
- Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
- Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations
- Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
- Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
- Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement
- Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results
- Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
- Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
More ▼